Xun Mengzhao, Liu Xu, Sha Yongfang, Zhang Xin, Liu Jian Ping
ENT Institute and Department of Otorhinolaryngology, Eye and ENT Hospital Fudan University Shanghai China.
NHC Key Laboratory of Hearing Medicine (Fudan University) Shanghai China.
Laryngoscope Investig Otolaryngol. 2023 Apr 5;8(3):627-635. doi: 10.1002/lio2.1032. eCollection 2023 Jun.
The purpose of this meta-analysis was to compare the efficiency of high-resolution computed tomography (HRCT) and diffusion-weighted magnetic resonance imaging (DWI) in guiding the diagnosis of middle ear cholesteatoma in clinical practice.
Cochrane Library, Medline, Embase, PubMed, and Web of Science were searched for studies that evaluated the sensitivity and specificity of HRCT or DWI in detecting middle ear cholesteatoma. A random-effects model was used to calculate and summarize the pooled estimates of sensitivity, specificity, and diagnostic odds ratios. Postoperative pathological results were considered as the diagnostic gold standard for middle ear cholesteatoma.
Fourteen published articles (860 patients) met the inclusion criteria. The sensitivity and specificity of DWI when diagnosing cholesteatoma (regardless of type) were 0.88 (95% confidence interval [CI], 0.80-0.93) and 0.93 (95% CI, 0.86-0.97), respectively, while those of HRCT were 0.68 (95% CI, 0.57-0.77) and 0.78 (95% CI, 0.60-0.90), respectively. Notably, the sensitivity and specificity levels of DWI were similar to those of HRCT ( = .1178 for sensitivity, = .2144 for specificity; pair-sampled tests). The sensitivity and specificity of DWI or HRCT for the diagnosis of primary cholesteatoma were 0.78 (95% CI, 0.65-0.88) and 0.84 (95% CI, 0.69-0.93), respectively, while that for recurrent cholesteatoma were 0.93 (95% CI, 0.61-0.99) and 0.94 (95% CI, 0.82-0.98), respectively.
DWI and HRCT have similar levels of high sensitivity and specificity in detecting various cholesteatomas. Also, the diagnostic efficiency of HRCT or DWI for recurrent cholesteatoma is identical to that of primary cholesteatoma. Therefore, HRCT may be used in clinical settings to reduce the use of DWI and save clinical resources.
Data on the use of diffusion-weighted magnetic resonance imaging and high-resolution computed tomography in the diagnosis of cholesteatoma were obtained through a literature search. They were analyzed to guide the clinical diagnosis and treatment of cholesteatoma.
NA.
本荟萃分析的目的是比较高分辨率计算机断层扫描(HRCT)和扩散加权磁共振成像(DWI)在临床实践中指导中耳胆脂瘤诊断的效率。
检索Cochrane图书馆、Medline、Embase、PubMed和Web of Science,查找评估HRCT或DWI检测中耳胆脂瘤的敏感性和特异性的研究。采用随机效应模型计算并汇总敏感性、特异性和诊断比值比的合并估计值。术后病理结果被视为中耳胆脂瘤的诊断金标准。
14篇已发表文章(860例患者)符合纳入标准。DWI诊断胆脂瘤(无论类型)时的敏感性和特异性分别为0.88(95%置信区间[CI],0.80 - 0.93)和0.93(95%CI,0.86 - 0.97),而HRCT的敏感性和特异性分别为0.68(95%CI,0.57 - 0.77)和0.78(95%CI,0.60 - 0.90)。值得注意的是,DWI的敏感性和特异性水平与HRCT相似(敏感性P = 0.1178,特异性P = 0.2144;配对样本t检验)。DWI或HRCT诊断原发性胆脂瘤的敏感性和特异性分别为0.78(95%CI,0.65 - 0.88)和0.84(95%CI,0.69 - 0.93),而诊断复发性胆脂瘤的敏感性和特异性分别为0.93(95%CI,0.61 - 0.99)和0.94(95%CI,0.82 - 0.98)。
DWI和HRCT在检测各种胆脂瘤方面具有相似的高敏感性和特异性水平。此外,HRCT或DWI对复发性胆脂瘤的诊断效率与原发性胆脂瘤相同。因此,HRCT可用于临床,以减少DWI的使用并节省临床资源。
通过文献检索获得了关于扩散加权磁共振成像和高分辨率计算机断层扫描在胆脂瘤诊断中应用的数据。对这些数据进行分析以指导胆脂瘤的临床诊断和治疗。
无。